Navigation Links
Maryland Stem Cell Research Commission Presents Sixth Annual Maryland Stem Cell Research Symposium in Baltimore

BALTIMORE, Dec. 3, 2013 /PRNewswire/ -- Each year, the State of Maryland continues to lead advancements and best practices in U.S. stem cell research through the Maryland Stem Cell Research Fund (MSCRF). To celebrate and share the most current research coming out of the state, more than 350 scientists, researchers, bioethicists, patient advocates, government officials and members of the public came together today to attend the Sixth Annual Maryland Stem Cell Research Symposium at Johns Hopkins University School of Medicine Campus in Baltimore. Hosted by The Maryland Stem Cell Research Commission (Commission), the event delivered plenary sessions, concurrent presentations, more than 100 poster exhibits and 20 comprehensive scientific presentations on stem cell studies presented by Maryland researchers.

During the Symposium, researchers discussed how to translate cell therapy basic research and technologies, from the lab to pre-clinical and commercialization. This year's Symposium featured many stem cell topics such as Induced Pluripotent Stem Cell (iPSC) technology for liver diseases and drug toxicity, Gaucher Disease-specific hematopoietic progenitor cells, regenerative medicine to treat genetic and autoimmune diseases, and hydrogel and vascular stem cells to augment diabetic wound healing.

"One of our high priorities has always been to educate the public on the importance of stem cell research and our annual Symposium highlights pioneering projects and findings from Maryland's top stem cell researchers," said Rabbi Avram Reisner, Chair of the Commission. "Stem cell research is always evolving and our Symposium provides an opportunity for the research community and the public to come together for workshops and networking opportunities to facilitate collaboration and promote best practices."

Highlights of the Symposium included The John L. Kellermann III Memorial Lecture which was presented by Rita Perlingeiro, Associate Professor and Lillehei Endowed Scholar at Lillehei Heart Institute at the University of Minnesota. Her keynote address discussed the potential for gene correction and therapeutic application with iPS cells to skeletal muscle precursors. Other speakers included representatives from the MSCRF, The Johns Hopkins School of Medicine, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, University of Maryland School of Medicine, University of Maryland Baltimore, the Hugo W. Moser Research Institute at Kennedy Krieger Research Institute, and the National Institute of Child Health and Human Development. For a full agenda visit

About the Maryland Stem Cell Research Commission
The Maryland Stem Cell Research Fund (MSCRF) was established by the State of Maryland under the Maryland Stem Cell Research Act of 2006 to promote State-funded stem cell research and cures through grants and loans to public and private entities in the State. Administered by The Maryland Technology Development Corporation (TEDCO), the MSCRF is overseen by an independent Commission that sets policy and develops criteria, standards and requirements for applications to the Fund. The current MSCRF budget for FY2014 is $10.4 million. For more information about the Maryland Stem Cell Research Fund and a list of Commission members, please visit

SOURCE The Maryland Stem Cell Research Fund
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. University of Maryland School of Medicine Holds First "Festival of Science" to Launch New Program for Accelerating Innovation and Discovery in Medicine
2. Cato Research Presents at Korea-Maryland, USA BIO EXPO, Drug Development Process and Regulatory Approaches
3. Alpha Technics Selected to Design Sensor for Joint FDA and University of Maryland Scientific Study
4. PointCross Life Sciences Opens New Office in Silver Spring, Maryland for Data Standardization of Nonclinical Studies
5. MAX Launches "Double HELIX" in Marylands Biotechnology Corridor
6. Global Virus Network Opens Headquarters in the University of Maryland BioPark
7. University of Maryland Breast Cancer Research Pioneer Dr. Angela Brodie Appointed Fellow of New American Association for Cancer Research Academy
8. BioHealth Innovation, Inc. Forms Commercial Relevance Advisory Board to Help Advance Market-Relevant Innovations in Central Maryland
9. Recently FDA-Approved Full Neck Treatment for Sagging Skin Now Available at Maryland Laser Skin and Vein Institute
10. First Maryland Hospital Offering 3D Mammograms? VA Maryland Health Care System
11. Systems Alliance Launches Redesigned Website for The Living Legacy Foundation of Maryland
Post Your Comments:
(Date:11/27/2015)... 27, 2015 ... of companion diagnostics is one of the ... with pharmaceutical companies and diagnostic manufacturers working ... . --> ... on global cancer biomarkers market spread across ...
(Date:11/25/2015)... -- 2 nouvelles études permettent d , ... entre les souches bactériennes retrouvées dans la plaque ... . Ces recherches  ouvrent une nouvelle voie ... efficace de l,un des problèmes de santé les ...    --> 2 nouvelles études permettent d ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... of Black Aerospace Professionals (OPBAP) has been formalized with the signing of a ... leaders met with OPBAP leaders Capt. Karl Minter and Capt. Albert Glenn Tuesday, ...
(Date:11/24/2015)... ... , ... The United States Golf Association (USGA) today announced Dr. Bruce Clarke, ... annually since 1961, the USGA Green Section Award recognizes an individual’s distinguished service to ... Clarke, of Iselin, N.J., is an extension specialist of turfgrass pathology in the department ...
Breaking Biology Technology:
(Date:11/9/2015)... 9, 2015  Synaptics Inc. (NASDAQ: SYNA ), ... broader entry into the automotive market with a comprehensive ... pace of consumer electronics human interface innovation. Synaptics, industry-leading ... for the automotive industry and will be implemented in ... Europe , Japan , and ...
(Date:11/2/2015)... MENLO PARK, Calif. , Nov. 2, 2015 /PRNewswire/ ... to $9 million to provide preclinical development services to ... Under the contract, SRI will provide scientific expertise, modern ... a wide variety of preclinical pharmacology and toxicology studies ... --> --> The PREVENT Cancer Drug ...
(Date:10/29/2015)... Calif. , Oct. 29, 2015  The J. ... new report titled, "DNA Synthesis and Biosecurity: Lessons Learned ... the Department of Health and Human Services guidance for ... in 2010. --> ... it also has the potential to pose unique biosecurity ...
Breaking Biology News(10 mins):